Eledon Pharmaceuticals (ELDN) Other Accumulated Expenses (2013 - 2026)

Eledon Pharmaceuticals (ELDN) has 14 years of Other Accumulated Expenses data on file, last reported at $55000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 31.25% year-over-year to $55000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55000.0 (down 31.25% YoY) and the FY2025 annual result came in at $632000.0, up 1244.68% from the prior year.
• Other Accumulated Expenses slipped to $55000.0 in Q1 2026, from $632000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $705000.0 in Q2 2024 to a low of $13000.0 in Q2 2022.
• A 5-year average of $127176.5 and a median of $50000.0 in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses surged 1755.26% — and 2025, when it sank 95.89%.
• Tracing ELDN's Other Accumulated Expenses over 5 years: stood at $112000.0 in 2022, then plunged by 60.71% to $44000.0 in 2023, then grew by 6.82% to $47000.0 in 2024, then jumped by 1244.68% to $632000.0 in 2025, then sank by 91.3% to $55000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $55000.0 (Q1 2026), $632000.0 (Q4 2025), and $52000.0 (Q3 2025), per Business Quant data.